Expression and Release of the Monocyte Lipopolysaccharide Receptor Antigen CD14 Are Suppressed by Glucocorticoids in Vivo and in Vitro

Journal of Immunology

Volumn 158, Issue 3, 1997, Pages 1345-1352

  Nockher, Wolfgang A ^a   Scherberich, Jürgen E ^b,c  

^a GOETHE UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c Abteilung fur Neurologie Stroke Unit Stad Krankenhaus Munchen Harlaching   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; DIFFERENTIATION ANTIGEN; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 1; LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; CELL CULTURE; CELL MEMBRANE; DOSE RESPONSE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MONOCYTE; SECRETION; SOLUBILITY; TIME;

ADULT; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL MEMBRANE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; MONOCYTES; SOLUBILITY; TIME FACTORS;

EID: 0031066828     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Fauci, A.S. 1979. Immunosuppressive and anti-inflammatory effects of glucocorticoids. In Glucocorticoid Hormone Action. J. Baxter and G. Rousseau, eds. Springer Publishing Co., Inc., New York, p. 449.
2. Beato, M. 1989. Gene regulation by steroid hormones. Cell 56:335.
3. Fauci, A. S., D. C. Dale, and J. E. Balow. 1976. Glucocorticosteroid therapy; mechanisms of action and clinical considerations. Ann. Intern. Med. 84:304.
4. Werb, Z., R. Foley, and A. Munck. 1978. Interaction of glucocorticoids with macrophages. Identitication of glucocorticoid receptors in monocytes and macrophages. J. Exp. Med. 147:1684.
5. Thompson, J., and R. van Furth. 1970. The effect of glucocorticosteroids on the kinetics of mononuclear phagocytes. J. Exp. Med. 131:429.
6. Thompson, J., and R. van Furth. 1973. The effect of glucocorticosteroids on the proliferation and kinetics of promonocytes and monocytes of the bone marrow. J. Exp. Med. 137:10.
7. Leibovichm S. J., and R. Ross. 1975. The role of the macrophage in wound repair. Am. J. Pathol. 78:71.
8. Rinehart, J. J., S. T. Balcerzak, A. L. Sagone, and A. F. LoBuglio. 1974. Effects of corticosteroids on human monocyte function. J. Clin. Invest. 54:1337.
9. Schaffner, A. 1985. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J. Clin. Invest. 76:1755.
10. Masur, H., H. W. Murray, and T. C. Jones. 1982. Effect of hydrocortisone on macrophage response to lymphokine. Infect. Immun. 35:709.
11. Ialenti, A., A. Calignano, R., R. Carnuccio, and M. Di Rosa. 1986. Glucocorticoid induction of angiotensin converting enzyme. Agents Actions 17:294.
12. Werb, Z. 1978. Biochemical actions of glucocorticoids on macrophages in cultures. Specific inhibition of elastase, collagenase and plasminogen activator secretion and effects on other metabolic functions. J. Exp. Med. 147:1695.
13. Lew, W., J. J. Oppenheim, and K. Matsushima. 1988. Analysis of the suppression of IL-1α and IL-1β production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J. Immunol. 140:1895.
14. Waage, A., and O. Bakke. 1988. Glucocorticoids suppress the production of tumor necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology 63:299.
15. Schreiber, A. D., J. Parons, P. McDermott, and R. A. Cooper. 1975. Effect of corticosteroids on the human monocyte IgG and complement receptors. J. Clin. Invest. 56:1189.
16. Hirsch, L. J., and T. Mazzone. 1986. Dexamethasone modulates lipoprotein metabolism in cultured human monocyte-derived macrophages. J. Clin. Invest. 77:485.
17. Zwadlo, G., E. B. Bröcker, D. B. von Bassewitz, U. Feige, and C. Sorg. 1985. A monoclonal antibody to a differentiation antigen present on mature human macrophages and absent from monocytes. J. Immunol. 134:1487.
18. Zwadlo, G., R. Voegeli, K. Schulze Osthoff, and C. Sorg. 1987. A monoclonal antibody to a novel differentiation antigen on human macrophages associated with the down regulatory phase of the inflammatory process. Exp. Cell Biol. 55:295.
19. Morganelli, P. M., and P. M. Guyre. 1988. Interferon-γ plus corticosteroids stimulate the expression of a newly identified human mononulear phagocyte-specific Ag. J. Immunol. 140:2296.
20. Rhodes, J., J. Ivanyi, and P. Cozens. 1986. Antigen presentation by human monocytes: effects of modifying major histocompatibility complex class II antigen expression and interleukin 1 production by using recombinant interferons and corticosteroids. Eur. J. Immunol. 16:370.
21. Haziot, A., S. Chen, E. Ferrero, M. G. Low, R. Silber, and S. M. Goyert. 1988. The monocyte differentiation antigen CD14 is anchored to the cell membrane by a phosphatidylinositol linkage. J. Immunol. 141:547.
22. Wright, S. D., R. A. Ramos, P. S. Tobias, R. I. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431.
23. Hailman, E., H. S. Lichenstein, M. M Wurfel, D. S. Miller, D. A. Johnson, M. Kelley, L. A. Busse, M. M. Zukowski, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179:269.
24. Gegner, J. A., R. I. Ulevitch, and P. S. Tobias. 1995. Lipopolysaccharide (LPS) signal transduction and clearance. Dual role for LPS binding protein and membrane CD14. J. Biol. Chem. 270:5320.
25. Bazil, V., and I. Strominger. 1991. Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J. Immunol. 147:1567.
26. Grunwald, U., C. Krüger, J. Westermann, A. Lukowsky, E. Ehlers, and C. Schütt. 1992. An enzyme-linked immunosorbent assay for the quantification of solubilized CD14 in biological fluids. J. Immunol. Methods 155:225.
27. Krüger, C., C. Schütt, U. Obertacke, T. Joka, F. E. Müller, J. Knöller, M. Köller, W. König, and W. Schönfeld. 1992. Serum CD14 levels in polytraumatized and severely burned patients. Clin. Exp. Immunol. 85:297.
28. Nockher, W. A., and J. E. Scherberich. 1994. Increased soluble CD14 serum levels and altered CD14 expression of peripheral blood monocytes in HIV-infected patients. Clin. Exp. Immunol. 98:369.
29. Homolka, J., J. Lorenz, H. D. Zuchold, and J. Müller-Quernheim. 1992. Evaluation for soluble CD14 and neopterin as serum parameters of the inflammatory activity of pulmonary sarcoidosis. Clin. Invest. 70:909.
30. Frey, E. A., D. S. Miller, T. G. Jahr, A. Sundan, V. Bazil, T. Espevik, B. B. Finlay, and S. D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665.
31. Tobias, P. S., K. Soldau, J. A. Gegner, D. Mintz, and R. J. Ulevitch. 1995. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270:10482.
32. Haziot, A., G. W. Rong, J. Silver, and S. M. Goyert. 1993. Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151:1500.
33. Pugin, J., C. C. Schurer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90:2744.
34. Peterson, P. K., G. Gekker, S. Hu, W. S. Sheng, W. R. Anderson, R. J. Ulevitch, P. S. Tobias, K. V. Gustafson, T. W. Molitor, and C. C. Chao. 1995. CD14 receptor-mediated uptake of nonopsonized Mycobacterium tuberculosis by human microglia. Infect. Immun. 63:1598.
35. Lauener, R. P., S. M. Goyert, R. S., Geha, and D. Vercelli. 1990. Interleukin 4 down-regulates the expression of CD14 in normal human monocytes. Eur. J. Immunol. 20:2375.
36. Landmann, R., M. Wesp, C. Ludwig, R. Obrist, C. Knüsli, and J. P. Obrecht. 1990. Recombinant Interferon γ up-regulates in vivo and down-regulates in vitro monocyte CD14 antigen expression in cancer patients. Cancer Immunol. Immunother. 31:292.
37. Marchant, A., J. Duchow, J.-P. Delville, and M. Goldman. 1992. Lipopolysaccharide induces up-regulation of CD14 molecule on monocytes in human whole blood. Eur. J. Immunol. 22:1663.
38. Nockher, W. A., and J. E. Scherberich. 1995. Monocyte cell-surface CD14 expression and soluble CD14 antigen in hemodialysis: evidence for chronic exposure to LPS. Kidney Int. 48:1469.
39. Nockher, W. A., R. Wigand, W. Schoeppe, and J. E. Scherberich. 1994. Elevated levels of soluble CD14 in patients with lupus erythematosus. Clin. Exp. Immunol. 96:15.
40. Böyum, A. 1983. Isolation of human blood monocytes with Nycodenz, a new non-ionic iodinated gradient medium. Scand. J. Immunol. 17:429.
41. + population of monocytes in inflammatory bowel disease mucosa-implications for pathogenesis. Clin. Exp. Immunol. 100:291.
42. Thomson, A. W., and J. V. Forrester. 1994. Therapeutic advances in immunosuppression. Clin. Exp. Immunol. 98:351.
43. Rubin, R. H. 1993. Infectious disease complications of renal transplantation. Kidney Int. 44:221.
44. Thayer, C., S. T. Barlett, and R. Ward. 1990. Increased septic complications with three-drug sequential immunosuppression for cadaver renal transplants. Am. J. Surg. 160:1614.
45. Van Zwet, T. L., J. Thompson, and R. Van Furth. 1975. Effect of glucocorticosteroids on phagocytosis and intracellular killing by peritoneal macrophages. Infect. Immun. 12:699.
46. Couturier, C., G. Jahns, M. D. Kazatchkine, and N. Haeffner-Cavaillon. 1992. Membrane molecules which trigger the production of interleukin-1 and tumor necrosis factor-α by lipopolysaccharide-stimulated human monocytes. Eur. J. Immunol. 22:1461.
47. Lue, K.-H., R. P. Lauener, R. J. Winchester, R. S. Geha, and D. Vercelli. 1991. Engagement of CD14 on human monocytes terminates T cell proliferation by delivering a negative signal to T cells. J. Immunol. 147:1134.
48. Lund-Johansen, F., J. Olweus, F. W. Symington, A. Arli, J. S. Thompson, R. Vilella, K. Skubitz, and V. Horejsi. 1993. Activation of human monocytes and granulocytes by monoclonal antibodies to glycosylphosphatidylinositol-anchored Ag. Eur. J. Immunol. 23:2782.
49. Ziegler-Heitbrock, H. W. L., and R. J. Ulevitch. 1993. CD14: cell surface receptor and differentiation marker. Immunol. Today 14:121.
50. Tobias, P. S., K. Soldau, L. Kline, J.-D. Lee, K. Kato, T. P. Martin, and R. J. Ulevitch. 1993. Cross-linking of lipopolysaccharide (LPS) on CD14 on THP-1 cells mediated by LPS-binding protein. J. Immunol. 150:3011.
51. Viriyakosol, S., and T. N. Kirkland. 1995. A region of human CD14 required for lipopolysaccharide binding. J. Biol. Chem. 270:361.
52. Jack, R. S., V. Grunwald, F. Slelter, G. Workalemahu, and C. Schütt. 1995. Both membrane-bound and soluble forms of CD14 bind to Gram-negative bacteria. Eur. J. Immunol. 25:1436.
53. Bufler, P., G. Stiegler, M. Schuchmann, S. Hess, C. Krüger, F. Stelter, C. Eckerskorn, C. Schütt, and H. Engelmann. 1995. Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants. Eur. J. Immunol. 25:604.
54. Mc Ginley, M. D., L. O. Narhi, M. J. Kelley, E. Davy, J. Robinson, M. F. Rohde, S. D. Wright, and H. S. Lichenstein. 1995. CD14: physical properties and identification of an exposed site that is protected by lipopolysaccharide. J. Biol. Chem. 270:5213.
55. Juan, T. S., E. Hailman, M. J. Kelley, L. A. Busse, E. Davy, C. J. Empig, L. O. Narhi, S. D. Wright, and H. S. Lichenstein. 1995. Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64. J. Biol. Chem. 270:5219.
56. Juan, T. S., M. J. Kelley, D. A. Johnson, L. A. Busse, E. Hailman, S. D. Wright, and H. S. Lichenstein. 1995. Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular responses to LPS. J. Biol. Chem. 270:1382.
57. Loppnow, H., F. Stelter, U. Schonbeck, C. Schluter, M. Ernst, C. Schütt, and H. D. Flad. 1995. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogeneous membrane CD14. Infect. Immun. 63:1020.
58. Arditi, M., J. Zhou, R. Dorio, G. W. Rong, S. M. Goyert, and K. S. Kim. 1993. Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14. Infect. Immun. 61:3149.
59. Goldblum, S. E., T. W. Brann, X. Ding, J. Pugin, and P. S. Tobias. 1994. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function in vitro. J. Clin. Invest. 93:692.
60. Haziot, A., G. W. Rong, V. Bazil, J. Silver, and S. M. Goyert. 1994. Recombinant soluble CD14 inhibits LPS-induced tumor necrosis factor-α production by cells in whole blood. J. Immunol. 152:5868.
61. Haziot, A., G. W. Rong, X. Y. Lin, J. Silver, and S. M. Goyert. 1995. Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). J. Immunol. 154:6529.
62. Wan, Y., P. D. Freeswick, L. S. Khemlani, P. H. Kispert, S. C. Wang, G. L. Su, and T. R. Billiar. 1995. Role of lipopolysaccharide (LPS) interleukin-1, interleukin-6, tumor necrosis factor, and dexamethasone in regulation of LPS-binding protein expression in normal hepatocytes and hepalocytes from LPS-treated rats. Infect. Immun. 63:2435.